Design Therapeutics, Inc. (DSGN)
15.10
-0.15
(-0.98%)
USD |
NASDAQ |
Aug 28, 16:00
15.09
-0.01
(-0.07%)
After-Hours: 20:00
Design Therapeutics EPS Diluted (Quarterly) : -0.3226 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3226 |
| March 31, 2026 | -0.2871 |
| December 31, 2025 | -0.2724 |
| September 30, 2025 | -0.2984 |
| June 30, 2025 | -0.3356 |
| March 31, 2025 | -0.3121 |
| December 31, 2024 | -0.2408 |
| September 30, 2024 | -0.2303 |
| June 30, 2024 | -0.2085 |
| March 31, 2024 | -0.1966 |
| December 31, 2023 | -0.2109 |
| September 30, 2023 | -0.282 |
| June 30, 2023 | -0.3563 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3451 |
| December 31, 2022 | -0.3104 |
| September 30, 2022 | -0.3174 |
| June 30, 2022 | -0.2694 |
| March 31, 2022 | -0.239 |
| December 31, 2021 | -0.1996 |
| September 30, 2021 | -0.205 |
| June 30, 2021 | -0.1386 |
| March 31, 2021 | -0.1002 |
| September 30, 2020 | -0.0422 |
| June 30, 2020 | -0.0262 |
| March 31, 2020 | -0.0119 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 4.366 |
| AnaptysBio, Inc. | -1.843 |
| 4D Molecular Therapeutics, Inc. | -1.038 |
| Inhibrx Biosciences, Inc. | -2.339 |
| Agenus, Inc. | -0.0146 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.16M |
| Total Expenses (Quarterly) | 20.16M |
| Enterprise Value | 749.61M |
| Earnings Yield | -7.82% |
| Normalized Earnings Yield | -7.818 |